|
||||
|
|
||||||||||||
Affinitak (ISIS 3521 or LY900003) : ISIS Pharmaceuticals : Antisense Affinitak
Phase III Trial Results in NCLC (ISIS Pharmaceuticals)
|
|
|||||||||||
|
|
||||||||||||
|
Copyright © 1999-2006, Lung Cancer Online Foundation Last modified: 26-Apr-2011 Karen Parles, MLS Editor |